In recent years, China has emerged as a global leader in treating microtia, a congenital condition characterized by an underdeveloped outer ear. By performing around ten times more surgeries annually than Europe, Chinese medical teams are harnessing high volumes to refine their techniques.
Under the leadership of Professor Guo Shuzhong, surgeons have redesigned the conventional three-stage reconstructive surgery into an innovative two-stage process. This streamlined approach, paired with millimeter-level costal cartilage carving, reduces the treatment timeline while achieving a natural-looking ear shape.
Each year, this breakthrough benefits approximately 2,500 children in China. What’s more, families from countries and regions across the globe are now seeking out these procedures, drawn by the promise of world-class care and shorter recovery periods.
Data shows that high surgery volumes not only sharpen surgeons’ skills but also fuel ongoing research into biocompatible materials and post-surgery rehabilitation, ensuring continuous improvements in outcomes and patient experience.
Beyond numbers, this advancement reflects a broader philosophy of physicians without borders. Chinese doctors are leveraging cutting-edge technology and surgical expertise to rewrite the story of microtia patients everywhere, offering new confidence and opportunities for children worldwide.
Reference(s):
cgtn.com
